Tempus introduces loop, an ai-powered target discovery and validation platform

Chicago--(business wire)--tempus ai, inc. (nasdaq: tem), a technology company leading the adoption of ai to advance precision medicine and patient care, today announced tempus loop, a new oncology-focused platform for target discovery and validation. loop is tempus' proprietary approach to novel target identification that integrates real-world patient data (rwd) with human-derived biological models and crispr-screens, all leveraging ai to rapidly uncover insights for pre-clinical therapeutic de.
TEM Ratings Summary
TEM Quant Ranking